(Total Views: 80)
Posted On: 08/10/2023 2:50:50 PM
Post# of 107165
$CBAY News Article - CymaBay Initiates IDEAL, a Phase 3 Placebo-Controlled, Randomized Study of Seladelpar in Patients with Primary Biliary Cholangitis and Incomplete Control of Alkaline Phosphatase https://marketwirenews.com/news-releases/cyma...03072.html
(0)
(0)
My Twitter: WhyteStocks
